The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventions.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 34739831.
- Also identified by DOI 10.1016/j.stem.2021.10.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In March 2021, 1,480 U.S. businesses operating 2,754 clinics were found selling purported stem cell treatments for various indications. More than four times as many businesses than were identified 5 years ago are selling stem cell products that are not FDA-approved and lack convincing evidence of safety and efficacy.
Medical subject headings
- Commerce
- Stem Cell Transplantation